Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Railtrack still on time

Article Abstract:

Railtrack has seen a rise in its stock price since the company was privatized and the company could benefit from the government's emphasis on railroads. There could also be problems if the regulatory regime is tough. Two brokers from a sample of six rate the company's stocks a buy, three rate them a hold, and one rates them a sell. The buyers are UBS and Panmure Gordon, while NatWest Securities is among the holders. Williams de Broe and Daiwa are the other two holders, while SBC Warburg is the seller.

Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1997

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Railtrack link-linked

Article Abstract:

Railtrack has seen an increase in its stock prices after an agreement on the construction of a high-speed railroad link. Three brokers of a sample of six rate the company's stocks a buy, and they are BT Alex Brown, Dresdner Kleinwort Benson and SG Securities, which all see Railtrack as performing well in terms of cost reductions and likely to benefit from benign regulation. Paribas rates the company's stocks a hold, and HSBC Securities and Charterhouse Tilney rate them a sell.

Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1998

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Network Rail Infrastructure Ltd., Railroads, Securities
Similar abstracts:
  • Abstracts: Omnimedia: on track to deliver on its promise. Talking history. Epic hopes for a hit with drowned god
  • Abstracts: The corporate skyline. Still on the drawing board
  • Abstracts: International legal expertise. Legal liver birds
  • Abstracts: The deflation menace. Index-linked records broken
  • Abstracts: Russia: in from the cold. R is for revolution, roubles and risk
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.